Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nine Oxford academics have received European Research Council (ERC) Advanced Grants to fund cutting-edge research projects that address some of today’s most pressing challenges.

None © Shutterstock

The awards, funded through the EU and worth up to €2.5 million each, allow established top researchers from across disciplines to explore their most creative ideas. The grants will also lead to the creation of jobs including postdoctoral and doctoral research positions.

Projects led by Oxford include one that will make synthetic tissues for applications in medicine, and another probing the information flows between companies and consumers, filling a gap in economic understanding and policy.

The Oxford researchers receiving awards in the latest round of funding are:

  • Professor Mark Armstrong, Department of Economics          
  • Professor Hagan Bayley, Department of Chemistry
  • Professor Benjamin Berks, Department of Biochemistry
  • Professor Veronique Gouverneur, Department of Chemistry        
  • Professor Marta Kwiatkowska, Department of Computer Science
  • Professor Gero Miesenboeck, Department of Physiology, Anatomy and Genetics
  • Professor Melinda Mills, Department of Sociology
  • Professor Judith Rousseau, Department of Statistics
  • Professor Stuart West, Department of Zoology

Read more (Department of Physiology, Anatomy and Genetics website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.